BDO brought four prominent Black health care professionals together to discuss the lessons learned from the COVID-19 pandemic ...

The U.S. Food and Drug Administration approved two versions of the vaccine Aug. 22: the 2024-2025 Moderna COVID-19 Vaccine and the 2024-2025 Pfizer-BioNTech COVID-19 Vaccine. The Centers for ...

But it's not to go sightseeing or shopping. Wilhelm, who suffers from severe rheumatoid arthritis, hopes to get the updated Novavax COVID-19 vaccine, which won't be available in Canada as part of ...

Novavax (NVX-CoV2373) is a vaccine used to reduce the risk of serious infection from the virus that causes COVID-19. Novavax can cause side effects that range from mild to serious. Examples ...

Here's what to know about the latest vaccines, who needs them and how they ... authorization last week to an updated version of the Novavax shot, which includes a "monovalent (single) component ...

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and said the vaccine is ready to ship. Novavax received the green light from ...

Novavax, Inc., a Gaithersburg-based company advancing protein-based vaccines with its Matrix-M™ adjuvant, Tuesday announced its updated vaccine (Adjuvanted, 2024-2025 Formula, NVX-CoV2705 ...

U.S. regulators have cleared a third updated COVID-19 vaccine for this fall, shots made by Novavax Inc. Already, Pfizer and Moderna are shipping shots modified to better match more recent strains ...

Novavax NVAX announced that the FDA granted emergency use authorization (EUA) to an updated version of its protein-based COVID-19 vaccine for individuals aged 12 years and older. Following this ...

Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, announced the Novavax Covid-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) has received Emergency ...